• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性失代偿性心力衰竭患者院内新发房颤的临床意义。

The clinical implication of new-onset in-hospital atrial fibrillation in patients with acute decompensated heart failure.

作者信息

Kamioka Masashi, Yoshihisa Akiomi, Nodera Minoru, Misaka Tomofumi, Yokokawa Tetsuro, Kaneshiro Takashi, Nakazato Kazuhiko, Ishida Takafumi, Takeishi Yasuchika

机构信息

Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.

Department of Advanced Cardiac Therapeutics Fukushima Medical University Fukushima Japan.

出版信息

J Arrhythm. 2020 Jul 7;36(5):874-882. doi: 10.1002/joa3.12386. eCollection 2020 Oct.

DOI:10.1002/joa3.12386
PMID:34484475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8407291/
Abstract

BACKGROUND

To investigate the clinical implication of the temporal difference in atrial fibrillation (AF)-onset in acute decompensated heart failure (ADHF) and its impact on post-discharge prognosis.

METHODS

336 new-onset ADHF patients without any history of AF before admission were enrolled (201 males, 63 ± 16 year-old) and classified into two groups based on their history of AF: the Control group (No AF was detected during hospitalization, n = 278), and the In-hos-AF group (AF occurred during hospitalization, n = 58). Post discharge prognosis including rehospitalization due to worsening HF, cardiac death, all-cause death and cerebrovascular event were compared.

RESULTS

Kaplan-Meier analysis demonstrated that the incidence of rehospitalization due to HF, cardiac death, all-cause death and cerebrovascular event in the In-hos-AF group was not significantly different from that in the Control group ( > 0.05 respectively). However, when AF recurred in the In-hos-AF group patients (n = 24, 41%) after discharge, the incidence of rehospitalization due to HF and cardiac deaths were higher than those without AF recurrence ( = 0.018 and  = 0.027 respectively). Cox proportional analysis revealed that AF developing after discharge was proven to be an independent risk factor for rehospitalization due to HF (HR 1.845,  = 0.043), cardiac death (HR 3.562,  = 0.013) and all-cause deaths (HR 2.138,  = 0.020).

CONCLUSION

Clinical outcomes of new-onset in-hospital AF patients were as good as those without AF history until AF recurrence. However, AF recurrence led to worse prognosis. Therefore, treatment for new-onset in-hospital AF in ADHF patients might be postponed until AF recurrence.

摘要

背景

探讨急性失代偿性心力衰竭(ADHF)患者房颤(AF)发作时间差异的临床意义及其对出院后预后的影响。

方法

纳入336例入院前无房颤病史的新发ADHF患者(201例男性,63±16岁),根据房颤病史分为两组:对照组(住院期间未检测到房颤,n = 278)和住院期间房颤组(住院期间发生房颤,n = 58)。比较出院后预后,包括因心力衰竭恶化再次住院、心源性死亡、全因死亡和脑血管事件。

结果

Kaplan-Meier分析表明,住院期间房颤组因心力衰竭再次住院、心源性死亡、全因死亡和脑血管事件的发生率与对照组无显著差异(分别>0.05)。然而,住院期间房颤组患者出院后房颤复发(n = 24,41%)时,因心力衰竭再次住院和心源性死亡的发生率高于未复发房颤的患者(分别为=0.018和=0.027)。Cox比例分析显示,出院后发生房颤被证明是因心力衰竭再次住院(HR 1.845,=0.043)、心源性死亡(HR 3.562,=0.013)和全因死亡(HR 2.138,=0.020)的独立危险因素。

结论

新发院内房颤患者在房颤复发前的临床结局与无房颤病史的患者一样好。然而,房颤复发导致预后更差。因此,ADHF患者新发院内房颤的治疗可能推迟至房颤复发时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d23/8407291/720be7b1d635/JOA3-36-874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d23/8407291/438caafe9213/JOA3-36-874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d23/8407291/f063fe80de45/JOA3-36-874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d23/8407291/758975cabb72/JOA3-36-874-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d23/8407291/720be7b1d635/JOA3-36-874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d23/8407291/438caafe9213/JOA3-36-874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d23/8407291/f063fe80de45/JOA3-36-874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d23/8407291/758975cabb72/JOA3-36-874-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d23/8407291/720be7b1d635/JOA3-36-874-g002.jpg

相似文献

1
The clinical implication of new-onset in-hospital atrial fibrillation in patients with acute decompensated heart failure.急性失代偿性心力衰竭患者院内新发房颤的临床意义。
J Arrhythm. 2020 Jul 7;36(5):874-882. doi: 10.1002/joa3.12386. eCollection 2020 Oct.
2
Prognostic impact of new-onset atrial fibrillation associated with worsening heart failure in aging patients with severely decompensated acute heart failure.新出现的心房颤动对老年重度失代偿性急性心力衰竭患者心力衰竭恶化的预后影响。
Int J Cardiol. 2020 Mar 1;302:88-94. doi: 10.1016/j.ijcard.2019.09.020. Epub 2019 Sep 13.
3
Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction.心房颤动是射血分数保留的心力衰竭患者心力衰竭住院的独立危险因素。
ESC Heart Fail. 2022 Oct;9(5):2918-2927. doi: 10.1002/ehf2.13836. Epub 2022 Jun 16.
4
Clinical characteristics and in-hospital outcomes of acute decompensated heart failure patients with and without atrial fibrillation.伴有和不伴有心房颤动的急性失代偿性心力衰竭患者的临床特征和住院结局。
Anatol J Cardiol. 2020 Apr;23(5):260-267. doi: 10.14744/AnatolJCardiol.2020.94884.
5
Timing of Susceptibility to Mortality and Heart Failure in Patients With Preexisting Atrial Fibrillation After Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后合并心房颤动患者死亡和心力衰竭易感性的时机
Am J Cardiol. 2017 Nov 1;120(9):1618-1625. doi: 10.1016/j.amjcard.2017.07.061. Epub 2017 Jul 31.
6
Weekend vs. weekday admission and clinical outcomes in heart failure patients with and without atrial fibrillation in Taiwan.台湾地区伴或不伴心房颤动的心力衰竭患者周末与工作日入院与临床结局的比较。
Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):346-352. doi: 10.1093/ehjcvp/pvab047.
7
Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the Worcester Heart Failure Study).心力衰竭和心房颤动患者的发病率、治疗和预后的近期趋势(伍斯特心力衰竭研究)。
Am J Cardiol. 2013 May 15;111(10):1460-5. doi: 10.1016/j.amjcard.2013.01.298.
8
Prognostically Optimal Heart Rate at Discharge in Hospitalized Patients With Heart Failure and Atrial Fibrillation.心力衰竭合并心房颤动住院患者出院时的预后最佳心率
JACC Adv. 2024 Jul 24;3(8):101120. doi: 10.1016/j.jacadv.2024.101120. eCollection 2024 Aug.
9
Impact of Atrial Fibrillation on the Prognosis of Acute Decompensated Heart Failure With and Without Mitral Regurgitation.房颤对伴或不伴二尖瓣反流的急性失代偿性心力衰竭预后的影响。
Circ Rep. 2021 Jun 12;3(7):388-395. doi: 10.1253/circrep.CR-21-0027. eCollection 2021 Jul 9.
10
Clinical characteristics and predictors of one-year outcome of heart failure patients with atrial fibrillation compared to heart failure patients in sinus rhythm.与窦性心律心力衰竭患者相比,心房颤动心力衰竭患者的临床特征及一年期预后预测因素
Kardiol Pol. 2016;74(3):251-61. doi: 10.5603/KP.a2015.0180. Epub 2015 Sep 14.

引用本文的文献

1
Advances and controversies in acute decompensated heart failure treatment: beta-blocker roles, emerging devices, and future directions.急性失代偿性心力衰竭治疗的进展与争议:β受体阻滞剂的作用、新型器械及未来方向
Ann Med Surg (Lond). 2025 Jul 16;87(9):5696-5719. doi: 10.1097/MS9.0000000000003592. eCollection 2025 Sep.
2
Comparison of heart rate and cardiac output of VVI pacemaker settings in patients with atrial fibrillation with bradycardia.房颤伴心动过缓患者VVI起搏器设置下心率与心输出量的比较。
J Arrhythm. 2023 May 18;39(4):574-579. doi: 10.1002/joa3.12874. eCollection 2023 Aug.
3
Frequency of Atrial Fibrillation in Patients Presenting With Decompensated Heart Failure.

本文引用的文献

1
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.2017年心房颤动导管消融与外科消融治疗专家共识声明:由心律学会(HRS)、欧洲心律协会(EHRA)、欧洲心血管病预防与康复协会(ECAS)、亚太心律学会(APHRS)及拉丁美洲心脏学会(SOLAECE)联合发布
Heart Rhythm. 2017 Oct;14(10):e275-e444. doi: 10.1016/j.hrthm.2017.05.012. Epub 2017 May 12.
2
Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.射血分数降低的心房颤动和心力衰竭患者的治疗。
Circulation. 2017 Apr 18;135(16):1547-1563. doi: 10.1161/CIRCULATIONAHA.116.026054.
3
Prognostic Impact of New-Onset Atrial Fibrillation in Patients With Chronic Heart Failure - A Report From the CHART-2 Study.
失代偿性心力衰竭患者心房颤动的发生率
Cureus. 2021 Dec 22;13(12):e20594. doi: 10.7759/cureus.20594. eCollection 2021 Dec.
慢性心力衰竭患者新发心房颤动的预后影响——CHART-2研究报告
Circ J. 2016;80(1):157-67. doi: 10.1253/circj.CJ-15-0783. Epub 2015 Dec 7.
4
Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry.无症状性心房颤动:EORP-AF 试点普通登记处的临床相关性、管理和结局。
Am J Med. 2015 May;128(5):509-18.e2. doi: 10.1016/j.amjmed.2014.11.026. Epub 2014 Dec 20.
5
Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation.心力衰竭合并心房颤动患者的节律控制:包括消融作用在内的当代挑战
J Am Coll Cardiol. 2014 Aug 19;64(7):710-21. doi: 10.1016/j.jacc.2014.06.1169.
6
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》:欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组。与欧洲心脏病学会心力衰竭协会(HFA)合作制定。
Eur J Heart Fail. 2012 Aug;14(8):803-69. doi: 10.1093/eurjhf/hfs105.
7
What are the costs of heart failure?心力衰竭的治疗费用是多少?
Europace. 2011 May;13 Suppl 2:ii13-7. doi: 10.1093/europace/eur081.
8
Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study.慢性肾脏病与心房颤动之间的密切双向关系:新潟预防医学研究
Am Heart J. 2009 Oct;158(4):629-36. doi: 10.1016/j.ahj.2009.06.031.
9
Dabigatran versus warfarin in patients with atrial fibrillation.达比加群与华法林用于房颤患者的比较。
N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30.
10
A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure.一项关于心房颤动在慢性心力衰竭中的预后意义的荟萃分析。
Eur J Heart Fail. 2009 Jul;11(7):676-83. doi: 10.1093/eurjhf/hfp085.